MPM BioImpact is a world-leading biotechnology investment firm with nearly three decades of experience creating and investing in companies that seek to translate scientific innovations into cures for major diseases. With its world-class team and deep experience in scientific research, clinical development, and company-building, MPM BioImpact strives to power novel medical breakthroughs that transform patients’ lives. MPM BioImpact invests across the biotech landscape from early stage start-ups to public companies.
Looking for a particular MPM BioImpact employee's phone or email?
MPM BioImpact Questions
The MPM BioImpact annual revenue was $6.8 million in 2026.
Christopher Wolf is the CFO of MPM BioImpact.
66 people are employed at MPM BioImpact.
MPM BioImpact is based in Boston, Massachusetts.
The NAICS codes for MPM BioImpact are [52, 523, 5239].
The SIC codes for MPM BioImpact are [67, 679].
Top MPM BioImpact Employees
-
Christopher Wolf
Chief Financial Officer at MPM BioImpact
Boston, MA, US35+ -
Todd Foley
Managing Director at MPM BioImpact
Boston, MA, US25+ -
Kazumi Shiosaki
Managing Director at MPM BioImpact
Boston, MA, US4 -
Ansbert Gadicke
Managing Partner at MPM BioImpact
Boston, MA, US25+ -
Brendan Furey
Chief Compliance Officer at MPM BioImpact
Milton, MA, US23 -
Frank Neumann
Chief Medical Officer at MPM BioImpact
United States45 -
Vaughn Kailian
Managing Director at MPM BioImpact
Boston, MA, US15 -
Anne-Mari Paster
Chief Financial Officer at MPM BioImpact
Lexington, MA, US1 -
Ed Hurwitz
Managing Director at MPM BioImpact
Atherton, CA, US3
Related Companies
